Site Search
Displaying results 1 - 10 of 345
Resource | Publications,
Tuberculosis (TB) is a preventable and usually curable disease. Yet in 2022, TB was the world’s second leading cause of death from a single infectious agent, after coronavirus disease (COVID-19), and caused almost twice as many deaths as HIV/AIDS. More than 10 million people continue to fall ill with TB every year. Urgent action is required to end the global TB epidemic by 2030, a goal that has been adopted by all Member States of the United Nations (UN) and the World Health Organization (WHO).
Resource | Publications,
The assessment serves to document and review the situation in relation to the current human rights and gender related programmatic responses being implemented across the country, aimed at reducing barriers to services for key populations. For the purpose of this assessment the main key populations in Bangladesh include female sex workers (FSW), people who use drugs and populations with diverse sexual orientation, gender identity, and sexual characteristics and expression (SOGIESC) such as men who have sex with men (MSM), male sex workers (MSW) and Transgender people/Hijra/Third Gender (TG).
Resource | Publications,
Tuberculosis (TB) remains among the world’s top infectious killers. Each day, around 4000 people lose their lives to TB and around 30,000 people fall ill with this disease. This preventable and curable disease is deeply rooted in communities “left behind” - where poverty is pervasive and human rights and dignity are limited. The devastating social and economic impact on people affected and their families is profound.
This Status Update provides an overview of progress towards global TB targets set in the political declaration of the first UN High-Level Meeting on TB, spanning the period 2018- 2022. It is based primarily on data compiled by WHO’s Global TB Programme from all Member States in annual rounds of data collection.
Resource | Guidelines,
Infection prevention and control activities are amongst the key components envisaged by the End TB Strategy to curb the tuberculosis (TB) burden worldwide. The WHO operational handbook on tuberculosis. Module 1: prevention - infection prevention and control provides practical advice on how to implement the WHO recommendations on TB infection prevention and control, within the clinical and programmatic management of TB, using a public health approach. It is part of a modular series of practical guides meant for the implementers of various aspects of the programmatic management TB.
The handbook emphasizes the importance of building integrated, well-coordinated, multisectoral actions across all levels of health care and other settings where there is a high risk of M. tuberculosis transmission.
Resource | Publications,
The Operational guidance on adaptation and implementation of WHO’s Multisectoral Accountability Framework to end TB (MAF-TB) provides practical advice on key approaches and interventions needed to establish the MAF-TB at the national (and local) levels with concrete country examples, best practices and case studies under each suggested approach and interventions.
WHO consolidated guidelines on tuberculosis: Module 1: Prevention - infection prevention and control
Resource | Guidelines,
Infection prevention and control consists of evidence-based measures intended to prevent exposure and reduce the risk of transmission of infectious agents.
The revised guidelines contain recommendations for specific administrative, environmental controls and respiratory protection, following the assessment made by an external group of experts convened as members of the Guideline Development Group. Moreover, these guidelines focus on interventions specific to preventing transmission of Mycobacterium tuberculosis bridging with the core components of infection prevention and control programmes at the national and acute health care facility level.
Resource | Presentations,
UNAIDS new Global AIDS Update report shows 29.8 million of the 39 million [33.1 million–45.7 million] people living with HIV globally are receiving life-saving treatment. An additional 1.6 million people received HIV treatment in each of 2020, 2021 and 2022.
Resource | Publications,
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders involved in vaccine research, financing, regulation and policy-making, manufacturing, introduction and procurement. The goal is to accelerate development of effective vaccines against TB and their rapid introduction into countries.
Resource | Reviews and Snapshots,
Tuberculosis profiles are generated automatically based on data reported by countries and which are held in WHO's global TB database. The document includes data for estimates of TB burden, UHC and social protection, TB/HIV care in new and relapse TB patients, drug-resistant TB care in the country.
Resource | Reviews and Snapshots,
Tuberculosis profiles are generated automatically based on data reported by countries and which are held in WHO's global TB database. The document includes data for estimates of TB burden, UHC and social protection, TB/HIV care in new and relapse TB patients, drug-resistant TB care in the country.